Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGS
2601
DELISTED
PlayAGS
AGS
| $2.87M | ﹤0.01% |
290,215
+15,690
| +6% | +$145K |
|
2602
The Honest Company
HNST
$402M
| $2.87M | ﹤0.01% |
+177,486
| New | +$2.97M |
|
2603
Noodles & Co
NDLS
$111M
| $2.85M | ﹤0.01% |
28,541
+2,136
| +8% | +$199K |
|
2604
The Joint Corp
JYNT
$118M
| $2.85M | ﹤0.01% |
33,933
+563
| +2% | +$34.9K |
|
2605
Expro Ltd
XPRO
$1.79B
| $2.84M | ﹤0.01% |
156,110
+6,172
| +4% | +$127K |
|
|
ONT
2606
Onterris Inc
ONT
$759M
| $2.83M | ﹤0.01% |
52,702
+1,751
| +3% | +$92.2K |
|
2607
Root
ROOT
$857M
| $2.81M | ﹤0.01% |
14,413
+7,402
| +106% | +$1.4M |
|
|
KLRS
2608
Kalaris Therapeutics
KLRS
$83.5M
| $2.81M | ﹤0.01% |
6,183
-32
| -0.5% | -$16.5K |
|
|
GOCO
2609
DELISTED
GoHealth
GOCO
| $2.8M | ﹤0.01% |
16,659
+3,123
| +23% | +$547K |
|
2610
Grid Dynamics Holdings
GDYN
$576M
| $2.8M | ﹤0.01% |
186,170
+16,636
| +10% | +$261K |
|
|
EGIO
2611
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.77M | ﹤0.01% |
21,975
+2,704
| +14% | +$357K |
|
|
BNFT
2612
DELISTED
Benefitfocus, Inc.
BNFT
| $2.76M | ﹤0.01% |
195,984
+10,266
| +6% | +$145K |
|
2613
Pliant Therapeutics
PLRX
$64.4M
| $2.76M | ﹤0.01% |
94,879
+1,358
| +1% | +$42.3K |
|
2614
Dorian LPG
LPG
$2.03B
| $2.76M | ﹤0.01% |
195,293
-11,306
| -5% | -$158K |
|
2615
Gaotu Techedu
GOTU
$434M
| $2.7M | ﹤0.01% |
182,682
+127,142
| +229% | +$2.83M |
|
|
RJET
2616
Republic Airways Holdings
RJET
$967M
| $2.69M | ﹤0.01% |
19,232
+11,240
| +141% | +$1.81M |
|
2617
Vuzix
VUZI
$194M
| $2.67M | ﹤0.01% |
145,558
+127,862
| +723% | +$2.58M |
|
2618
ARS Pharmaceuticals
SPRY
$509M
| $2.65M | ﹤0.01% |
85,804
+1,391
| +2% | +$44.6K |
|
2619
Bank of Marin Bancorp
BMRC
$472M
| $2.65M | ﹤0.01% |
83,048
-11,186
| -12% | -$391K |
|
|
EVLO
2620
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $2.64M | ﹤0.01% |
9,609
+1,089
| +13% | +$275K |
|
2621
InnovAge Holding
INNV
$1.54B
| $2.63M | ﹤0.01% |
+123,561
| New | +$2.83M |
|
2622
Passage Bio
PASG
$14.4M
| $2.61M | ﹤0.01% |
9,851
+1,017
| +12% | +$315K |
|
|
FLXN
2623
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.6M | ﹤0.01% |
316,325
+14,470
| +5% | +$123K |
|
2624
Oportun Financial
OPRT
$255M
| $2.6M | ﹤0.01% |
129,843
+5,173
| +4% | +$106K |
|
2625
Alphatec Holdings
ATEC
$1.46B
| $2.57M | ﹤0.01% |
167,752
+27,614
| +20% | +$426K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.